Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease
- PMID: 23369757
- PMCID: PMC4720382
- DOI: 10.1016/j.freeradbiomed.2013.01.016
Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease
Abstract
The RCAN1 gene encodes three different protein isoforms: RCAN1-4, RCAN1-1L, and RCAN1-1S. RCAN1-1L is the RCAN1 isoform predominantly expressed in human brains. RCAN1 proteins have been shown to regulate various other proteins and cellular functions, including calcineurin, glycogen synthase kinase-3β (GSK-3β), the mitochondrial adenine nucleotide transporter (ANT), stress adaptation, ADP/ATP exchange in mitochondria, and the mitochondrial permeability transition pore (mtPTP). The effects of increased RCAN1 gene expression seem to depend both on the specific RCAN1 protein isoform(s) synthesized and on the length of time the level of each isoform is elevated. Transiently elevated RCAN1-4 and RCAN1-1L protein levels, lasting just a few hours, can be neuroprotective under acute stress conditions, including acute oxidative stress. We propose that, by transiently inhibiting the phosphatase calcineurin, RCAN1-4 and RCAN1-1L may reinforce and extend protective stress-adaptive cell responses. In contrast, prolonged elevation of RCAN1-1L levels is associated with the types of neurodegeneration observed in several diseases, including Alzheimer disease and Down syndrome. RCAN1-1L levels can also be increased by multiple chronic stresses and by glucocorticoids, both of which can cause neurodegeneration. Although increasing levels of RCAN1-1L for just a few months has no overtly obvious neurodegenerative effect, it does suppress neurogenesis. Longer term elevation of RCAN1-1L levels (for at least 16 months), however, can lead to the first signs of neurodegeneration. Such neurodegeneration may be precipitated by (RCAN1-1L-mediated) prolonged calcineurin inhibition and GSK-3β induction/activation, both of which promote tau hyperphosphorylation, and/or by (RCAN1-1L-mediated) effects on the mitochondrial ANT, diminished ATP/ADP ratio, opening of the mtPTP, and mitochondrial autophagy. We propose that RCAN1-1L operates through various molecular mechanisms, primarily dependent upon the length of time protein levels are elevated. We also suggest that models analyzing long-term RCAN1 gene overexpression may help us to understand the molecular mechanisms of neurodegeneration in diseases such as Alzheimer disease, Down syndrome, and possibly others.
Keywords: (mitochondrial) adenine nucleotide transporter; ANT; Alzheimer disease; Free radicals; GSK-3β; Mitochondria; Neurodegeneration; Oxidative stress; RCAN1; glycogen synthase kinase-3β; mitochondrial permeability transition pore; mtPTP; regulator of calcineurin 1.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures

Similar articles
-
Overexpression of Rcan1-1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy.Mol Cells. 2014 Nov;37(11):785-94. doi: 10.14348/molcells.2014.0103. Epub 2014 Nov 5. Mol Cells. 2014. PMID: 25377251 Free PMC article.
-
Do RCAN1 proteins link chronic stress with neurodegeneration?FASEB J. 2011 Oct;25(10):3306-11. doi: 10.1096/fj.11-185728. Epub 2011 Jun 16. FASEB J. 2011. PMID: 21680892 Free PMC article.
-
Rcan1-1L overexpression induces mitochondrial autophagy and improves cell survival in angiotensin II-exposed cardiomyocytes.Exp Cell Res. 2015 Jul 1;335(1):99-106. doi: 10.1016/j.yexcr.2015.05.003. Epub 2015 May 12. Exp Cell Res. 2015. PMID: 25978972
-
Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.Mol Neurobiol. 2014 Dec;50(3):1085-97. doi: 10.1007/s12035-014-8704-y. Epub 2014 Apr 22. Mol Neurobiol. 2014. PMID: 24752590 Review.
-
RCAN1-mediated calcineurin inhibition as a target for cancer therapy.Mol Med. 2022 Jun 18;28(1):69. doi: 10.1186/s10020-022-00492-7. Mol Med. 2022. PMID: 35717152 Free PMC article. Review.
Cited by
-
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation.J Biol Chem. 2015 Aug 21;290(34):21019-21031. doi: 10.1074/jbc.M115.639476. Epub 2015 Jul 8. J Biol Chem. 2015. PMID: 26157140 Free PMC article.
-
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead.Acta Pharm Sin B. 2024 Mar;14(3):1009-1029. doi: 10.1016/j.apsb.2023.10.023. Epub 2023 Nov 4. Acta Pharm Sin B. 2024. PMID: 38486982 Free PMC article. Review.
-
Glucocorticoid-mediated co-regulation of RCAN1-1, E4BP4 and BIM in human leukemia cells susceptible to apoptosis.Biochem Biophys Res Commun. 2015 Aug 7;463(4):1291-6. doi: 10.1016/j.bbrc.2015.06.106. Epub 2015 Jun 20. Biochem Biophys Res Commun. 2015. PMID: 26102033 Free PMC article.
-
Human Models Are Needed for Studying Human Neurodevelopmental Disorders.Am J Hum Genet. 2018 Dec 6;103(6):829-857. doi: 10.1016/j.ajhg.2018.10.009. Am J Hum Genet. 2018. PMID: 30526865 Free PMC article. Review.
-
RCAN1.4 mediates high glucose-induced matrix production by stimulating mitochondrial fission in mesangial cells.Biosci Rep. 2020 Jan 31;40(1):BSR20192759. doi: 10.1042/BSR20192759. Biosci Rep. 2020. PMID: 31894838 Free PMC article.
References
-
- Davies KJ, Ermak G, Rothermel BA, Pritchard M, Heitman J, Ahnn J, Henrique-Silva F, Crawford D, Canaider S, Strippoli P, Carinci P, Min KT, Fox DS, Cunningham KW, Bassel-Duby R, Olson EN, Zhang Z, Williams RS, Gerber HP, Perez-Riba M, Seo H, Cao X, Klee CB, Redondo JM, Maltais LJ, Bruford EA, Povey S, Molkentin JD, McKeon FD, Duh EJ, Crabtree GR, Cyert MS, de la Luna S, Estivill X. Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J. 2007;21:3023–3028. - PubMed
-
- Ermak G, Harris CD, Battocchio D, Davies KJ. RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta. FEBS J. 2006;273:2100–2109. - PubMed
-
- Crawford DR, Leahy KP, Abramova N, Lan L, Wang Y, Davies KJ. Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Arch. Biochem. Biophys. 1997;342:6–12. - PubMed
-
- Wang Y, De Keulenaer GW, Weinberg EO, Muangman S, Gualberto A, Landschulz KT, Turi TG, Thompson JF, Lee RT. Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2002;283:H533–539. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical